Two-Year Randomized Controlled Prospective Trial Converting Treatment of Stable Renal Transplant Recipients With Cutaneous Invasive Squamous Cell Carcinomas to Sirolimus Inhibin B was dichotomized as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback